Birch triterpenes

Jump to navigation Jump to search

Birch triterpenes
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rafael Garcia

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Birch triterpenes is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of FILSUVEZ (birch triterpenes) topical gel is used to treat wounds associated with dystrophic and junctional epidermolysis bullosa.. Common adverse reactions include The most common (incidence ≥2%) adverse reactions are application site reactions..

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

FILSUVEZ topical gel is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa.

Apply a 1 mm layer of FILSUVEZ to the affected wound surface and cover with wound dressing or apply FILSUVEZ directly to dressing so that the topical gel is in direct contact with the wound. Do not rub in the topical gel.

Off-Label Use and Dosage (Adult)

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

FILSUVEZ topical gel is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa.

Apply a 1 mm layer of FILSUVEZ to the affected wound surface and cover with wound dressing or apply FILSUVEZ directly to dressing so that the topical gel is in direct contact with the wound. Do not rub in the topical gel.

Off-Label Use and Dosage (Pediatric)

Contraindications

None.

Warnings

Hypersensitivity Reactions: If signs or symptoms of hypersensitivity occur, discontinue use immediately and initiate appropriate therapy.

Adverse Reactions

Clinical Trials Experience

The most common (incidence ≥2%) adverse reactions are application site reactions.

Postmarketing Experience

There is limited information regarding Birch triterpenes Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Birch triterpenes Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Birch triterpenes in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Birch triterpenes in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Birch triterpenes during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Birch triterpenes in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Birch triterpenes in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Birch triterpenes in geriatric settings.

Gender

There is no FDA guidance on the use of Birch triterpenes with respect to specific gender populations.

Race

There is no FDA guidance on the use of Birch triterpenes with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Birch triterpenes in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Birch triterpenes in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Birch triterpenes in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Birch triterpenes in patients who are immunocompromised.

Administration and Monitoring

Administration

Apply FILSUVEZ at wound dressing changes until the wound is healed. Each tube of FILSUVEZ is for one-time use only. For topical use; not for oral, intravaginal, intra-anal, or ophthalmic use.

Monitoring

There is limited information regarding Birch triterpenes Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Birch triterpenes and IV administrations.

Overdosage

There is limited information regarding Birch triterpenes overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Birch triterpenes Pharmacology in the drug label.

Mechanism of Action

The mechanism of action of FILSUVEZ in the treatment of wounds associated with epidermolysis bullosa is unknown.

Structure

There is limited information regarding Birch triterpenes Structure in the drug label.

Pharmacodynamics

There is limited information regarding Birch triterpenes Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Birch triterpenes Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Birch triterpenes Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Birch triterpenes Clinical Studies in the drug label.

How Supplied

There is limited information regarding Birch triterpenes How Supplied in the drug label.

Storage

There is limited information regarding Birch triterpenes Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Birch triterpenes |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Birch triterpenes |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Birch triterpenes Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Birch triterpenes interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Birch triterpenes Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Birch triterpenes Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.